A significant shift in Canadian drug policy has occurred, as the government permit the legalization of psilocybin mushrooms for therapeutic purposes. Until now, these substances were strictly restricted, but a mounting body of evidence suggests they may offer benefits for mental health illnesses like anxiety. The new policy represents a key step to